Login

Sandra Zinkel, M.D., Ph.D.

Assistant Professor

Phone: 615-936-1801
Fax:
Email: sandra.zinkel@vanderbilt.edu

Affiliations

Medicine
Cell & Developmental Biology
Cancer Biology

My lab is interested in understanding the mechanisms by which normal and malignant cells regulate programmed cell death or apoptosis following DNA damage. Multicellular organisms have devised a tightly regulated, genetically programmed mechanism of cell suicide to maintain homeostasis and to prevent propagation of genetically damaged cells. The discovery of the BCL-2 family of genes uncovered the underlying genetic mechanism of this regulation, as well as an entirely new class of oncogenes: those that govern cell death rather than cell proliferation.
Current studies focus on the pro-death BCL-2 family member BID. The deletion of BID in mice prolongs the lives of myeloid cells culminating in the development of a fatal disorder resembling the human disease chronic myelomonocytic leukemia (CMML). Our recent work has shown an additional role for BID in preserving genomic integrity that is distinct from its pro-apoptotic role. Following DNA damage, BID is phosphorylated by the DNA damage kinase ATM and plays a role in cell cycle checkpoint control. Cells initiate a complex series of responses subsequent to DNA damage including activation of cell cycle checkpoints, promoting DNA repair, or activating apoptosis. BID, with its dual function in apoptosis and the DNA damage response, is well situated to serve as a mediator in determining cell fate following DNA damage.
The projects in my lab use hematopoietic cell culture systems, mouse models, immunofluorescence, as well as apoptosis, cell cycle checkpoint and DNA repair assays to understand the signals and protein interactions that direct BID to assume an apoptotic or cell cycle checkpoint/DNA repair role following treatment with agents inducing DNA damage. An additional focus is to dissect the mechanism of Bcl-2 family members in mouse models of leukemia. Our studies provide new insights into the interplay between apoptosis and cell cycle checkpoint/DNA repair responses following DNA damage, and their role in myeloid homeostasis and leukemogenesis.

Publications

PubMedID Citation
18662573 Zinkel SS. Investigation of the proapoptotic BCL-2 family member bid on the crossroad of the DNA damage response and apoptosis. () Methods Enzymol 442: 231-50
16763616 Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. (2006) Cell Death Differ 13: 1351-9
16122425 Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ. A role for proapoptotic BID in the DNA-damage response. () Cell 122: 579-91
15635450 Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. (2005) EMBO J 24: 368-81
12533511 Zinkel SS, Ong CC, Ferguson DO, Iwasaki H, Akashi K, Bronson RT, Kutok JL, Alt FW, Korsmeyer SJ. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. () Genes Dev 17: 229-39

You can also view publications listed at PubMed.

VCSCB Faculty Investigators

Stacey S. Huppert
Assistant Professor
Patricia A. Labosky
Associate Professor
Mark A. Magnuson
Director


VCSCB Faculty Members

Scott Baldwin
Director & Professor
Aaron Bowman
Assistant Professor
Kevin C Ess
Assistant Professor
Guoqiang Gu
Assistant Professor
Antonis Hatzopoulos
Associate Professor
Scott Hiebert
Professor
Charles Hong
Assistant Professor
Robert Matusik
Professor
Douglas P. Mortlock
Assistant Professor
Lance Prince
Assistant Professor
Chris Wright
Professor
Sandra Zinkel
Assistant Professor